Rep. April McClain Delaney Sells Bio-Techne Corp Shares

Democratic Representative from Maryland discloses stock sale of $1,001 - $15,000 in biotech company

Mar. 12, 2026 at 6:06am

Got story updates? Submit your updates here. ›

Representative April McClain Delaney (Democratic-Maryland) recently sold between $1,001 and $15,000 worth of shares in Bio-Techne Corp (NASDAQ:TECH). The sale was disclosed in a filing on March 10th and occurred on February 24th.

Why it matters

As a member of Congress, Representative McClain Delaney's financial transactions are subject to public disclosure under the STOCK Act. This sale of Bio-Techne stock is one of several trades the Representative has made in recent weeks, raising questions about potential conflicts of interest or insider trading.

The details

In the March 10th filing, Representative McClain Delaney disclosed the sale of Bio-Techne stock valued between $1,001 and $15,000. This was one of several trades the Representative made in late February, including purchases of EMCOR Group and Nasdaq stock, as well as sales of Jones Lang LaSalle, Morningstar, Fortune Brands Innovations, CDW, and Paychex shares.

  • On February 24th, 2026, Representative McClain Delaney sold between $1,001 and $15,000 worth of Bio-Techne Corp stock.

The players

Representative April McClain Delaney

A Democratic member of the U.S. House of Representatives, representing Maryland's 6th Congressional District since 2025.

Bio-Techne Corp

A global life sciences company that develops, manufactures and sells high-quality reagents, instruments and services for the research, diagnostic and bioprocessing markets.

Got photos? Submit your photos here. ›

What’s next

The House Ethics Committee may investigate the series of trades made by Representative McClain Delaney to determine if any rules or laws were violated.

The takeaway

This case highlights the ongoing scrutiny over stock trades made by members of Congress and the potential conflicts of interest that can arise, even for routine financial transactions.